Revision as of 00:09, 27 October 2023 editKimen8 (talk | contribs)Extended confirmed users5,112 edits Changing short description from "Chemical compound" to "NSAID analgesic drug"Tag: Shortdesc helper← Previous edit | Revision as of 15:53, 9 December 2024 edit undoCitation bot (talk | contribs)Bots5,460,279 edits Added bibcode. | Use this bot. Report bugs. | Suggested by Dominic3203 | Linked from User:Marbletan/sandbox | #UCB_webform_linked 154/2664Next edit → | ||
Line 50: | Line 50: | ||
}} | }} | ||
'''Feprazone''' (or '''prenazone''') is a drug used for joint and muscular ].<ref>{{cite journal | vauthors = Koyama T, Izawa Y, Wada H, Makita T, Hashimoto Y, Enomoto M | title = Toxicological aspects of feprazone, a new nonsteroidal anti-inflammatory drug | journal = Toxicology and Applied Pharmacology | volume = 64 | issue = 2 | pages = 255–70 | date = June 1982 | pmid = 7123554 | doi = 10.1016/0041-008X(82)90222-8 }}</ref> | '''Feprazone''' (or '''prenazone''') is a drug used for joint and muscular ].<ref>{{cite journal | vauthors = Koyama T, Izawa Y, Wada H, Makita T, Hashimoto Y, Enomoto M | title = Toxicological aspects of feprazone, a new nonsteroidal anti-inflammatory drug | journal = Toxicology and Applied Pharmacology | volume = 64 | issue = 2 | pages = 255–70 | date = June 1982 | pmid = 7123554 | doi = 10.1016/0041-008X(82)90222-8 | bibcode = 1982ToxAP..64..255K }}</ref> | ||
It is an analog of ] but instead of a ''n''-butyl group it is ]. | It is an analog of ] but instead of a ''n''-butyl group it is ]. |
Revision as of 15:53, 9 December 2024
NSAID analgesic drug Pharmaceutical compoundClinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.045.735 |
Chemical and physical data | |
Formula | C20H20N2O2 |
Molar mass | 320.392 g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(verify) |
Feprazone (or prenazone) is a drug used for joint and muscular pain.
It is an analog of phenylbutazone but instead of a n-butyl group it is prenylated.
References
- Koyama T, Izawa Y, Wada H, Makita T, Hashimoto Y, Enomoto M (June 1982). "Toxicological aspects of feprazone, a new nonsteroidal anti-inflammatory drug". Toxicology and Applied Pharmacology. 64 (2): 255–70. Bibcode:1982ToxAP..64..255K. doi:10.1016/0041-008X(82)90222-8. PMID 7123554.
Non-steroidal anti-inflammatory drugs (NSAIDs) (primarily M01A and M02A, also N02BA) | |
---|---|
pyrazolones / pyrazolidines | |
salicylates | |
acetic acid derivatives and related substances | |
oxicams | |
propionic acid derivatives (profens) |
|
n-arylanthranilic acids (fenamates) | |
COX-2 inhibitors (coxibs) | |
other | |
NSAID combinations | |
Key: underline indicates initially developed first-in-class compound of specific group; WHO-Essential Medicines; withdrawn drugs; veterinary use. | |
Topical products for joint and muscular pain (M02) | |||||||
---|---|---|---|---|---|---|---|
Anti-inflammatory preparations, non-steroids |
| ||||||
Capsaicin derivatives | |||||||
Other |
This drug article relating to the musculoskeletal system is a stub. You can help Misplaced Pages by expanding it. |